Arch Biopartners Inc. - CNSX: ACH - News Update

Pacific Therapeutics is one of the latest new listings on the Canadian National Stock Exchange, better known as the CNSX, and trades under the...

Neptune Technologies & Bioresources Inc. researches, develops and commercializes proprietary bioactive ingredients and products with superior...

Established in 2003, Gemoscan owns and markets the Hemocode System, a well-being and lifestyle solution that with a simple, patented blood test...

Abattis Biologix is a specialty biotechnology company engaged in the development, licensing, sale and distribution of botanical-based antiviral...

Verisante Technology Inc. (TSXV: VRS) News Alert - Zacks Investment Research - Updated Recommendation

Pivotal Therapeutics is a publicly traded (CNSX: PVO) specialty pharmaceutical company with a focus on the treatment of cardiovascular diseases....

The VentriPoint Diagnostic System is based on patented technology used to create anatomically accurate reconstructions and corresponding...

Investment firm Canaccord Genuity, has initiated coverage on Exact Sciences, which trades on NASDAQ, under the symbol “EXAS”

Robin (Rob) B. Hutchison

MERUS LABS INTERNATIONAL INC. - CNSX: MR - News Update

Premier Diagnostic Health Services Inc (CNSX: PDH) Our business is advanced molecular imaging that provides physicians and healthcare professionals...

Asantae Holdings International Inc. is a producer and marketer of innovative nutritional products through direct and network marketing channels....

VentriPoint is dedicated to “connecting all the dots”, to improving the diagnosis of heart disease by increasing the accuracy, speed and ease of...

Toronto based eResearch has issued a new research report on Chemaphor Inc, which trades on the TSX Venture Exchange under the symbol CFR. eResearch...